AMENDMENT TO CONTRIBUTION AGREEMENTContribution Agreement • June 14th, 2010 • Neogenix Oncology Inc • In vitro & in vivo diagnostic substances • Maryland
Contract Type FiledJune 14th, 2010 Company Industry JurisdictionThis AMENDMENT TO CONTRIBUTION AGREEMENT (this “Amendment”) is entered into as of this 26th day of May, 2006, by and between ARIEL HOLLINSHEAD, an individual (the “Transferor”) and NEOGENIX ONCOLOGY INC., a Maryland corporation (“NOC”) and amends the Contribution Agreement between Transferor and NOC, dated as of December 10, 2004 (the “Agreement”). Capitalized terms not defined herein shall have the meaning as set forth in the Agreement.
CONTRIBUTION AGREEMENTContribution Agreement • June 14th, 2010 • Neogenix Oncology Inc • In vitro & in vivo diagnostic substances • Maryland
Contract Type FiledJune 14th, 2010 Company Industry JurisdictionThis CONTRIBUTION AGREEMENT (this “Agreement”) is entered into as of this 10th day of December, 2004, by and among ARIEL HOLLINSHEAD, an individual (the “Transferor”) and NEOGENIX ONCOLOGY CORP., a Maryland corporation (“NOC”).
PATENT PURCHASE AND TRANSFER AGREEMENTPatent Purchase and Transfer Agreement • June 14th, 2010 • Neogenix Oncology Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJune 14th, 2010 Company Industry JurisdictionThis Patent Purchase and Transfer Agreement (the “Agreement”) is entered into as of November 20, 2008 by and between Neogenix Oncology, Inc., a Maryland corporation (the “Buyer”), and International BioImmune Systems Inc., a Delaware corporation (“Seller”) and the other parties listed on the signature page.